ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,444
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Impact of patisiran, an investigational RNAi therapeutic, on nutritional status in patients with hereditary transthyretin-mediated amyloidosis
Author(s):
L Obici
,
T. COELHO
,
D Adams
,
A GONZALEZ-DUARTE
,
W O’Riordan
,
C-C YANG
,
T. YAMASHITA
,
A Kristen
,
I. Tournev
,
H Schmidt
,
J. Berk
,
K.-P. Lin
,
P Gandhi
,
M Sweetser
,
J. Chen
,
S Goyal
,
J. Gollob
,
O Suhr
Publication date:
2018
Journal:
Eur J Neurol
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
cGMP: Generators, Effectors and Therapeutic Implications Conference
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
2,444
Clinical update on Patisiran phase 2 trials in familial amyloidotic polyneuropathy
Authors:
O Suhr
Global open-label extension: 24-month data of patisiran in patients with hATTR amyloidosis
Authors:
D. ADAMS
Population pharmacokinetics (PK) of investigational patisiran in healthy volunteers and in patients
Authors:
V Goel
,
C Jomphe
,
N. Gosselin
See all similar
Cited by
1
Novel RNA-targeted therapies for hereditary ATTR amyloidosis and their impact on the autonomic nervous system
Authors:
Isabel Conceiçao
See all cited by